© WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Editorial Board Chairs: Antonello Mai, Rainer Metternich. Assoc. Editors: David Peralta, Scott Williams (Sr)
Impact Factor: 2.98
ISI Journal Citation Reports © Ranking: 2015: 18/59 (Chemistry Medicinal); 77/255 (Pharmacology & Pharmacy)
Online ISSN: 1860-7187
March 22, 2017
VIP: The Emerging Picture of Sulfoximines in Drug Discovery
Juan Alberto Sirvent, Dr. Ulrich Lücking*
After being neglected for a long time, sulfoximines, the mono-aza analogues of sulfones, have recently gained considerable recognition as a new and versatile structural motif in the life sciences. The synthetic methodology for sulfoximines has progressed significantly over the last decade; however, the general understanding of this functional group regarding its medicinal-chemistry-relevant properties is still limited. Read more...
Recently Published Articles
- Target Deconvolution Efforts on Wnt Pathway Screen Reveal Dual Modulation of Oxidative Phosphorylation and SERCA2
Dr. Matias Casás-Selves, Dr. Andrew X. Zhang, Dr. James E. Dowling, Dr. Stefan Hallén, Aarti Kawatkar, Dr. Nicholas J. Pace, Christopher R. Denz, Timothy Pontz, Farzin Garahdaghi, Qing Cao, Dr. Alan Sabirsh, Kumar Thakur, Dr. Nichole O'Connell, Dr. Jun Hu, Dr. Iván Cornella-Taracido, Prof. Dr. Eranthie Weerapana, Dr. Michael Zinda, Dr. Robert A. Goodnow Jr. and Dr. M. Paola Castaldi
Version of Record online: 26 APR 2017 | DOI: 10.1002/cmdc.201700028
Waste not, Wnt not: We identified a 1,2,3-thiadiazole-5-carboxamide chemical series in a Wnt pathway inhibition screen. We generated chemical probes to identify the targets of this series based on our efforts to optimize potency and physical properties. Using a combination of biochemical, cell biology, and chemoproteomics methods, we found two previously unreported mechanisms for this pharmacophore: uncouplers of the mitochondrial potential and Ca2+ ionophores through interaction with SERCA2.
- Immunogenicity of a fully synthetic MUC1-glycopeptide antitumor vaccine enhanced by poly(I:C) as TLR3-activating adjuvant
Horst Kunz, Markus Glaffig, Natascha Stergiou and Edgar Schmitt
Accepted manuscript online: 25 APR 2017 06:20AM EST | DOI: 10.1002/cmdc.201700254
- Probing Mercaptobenzamides as HIV Inactivators via Nucleocapsid Protein 7
Dr. Mrinmoy Saha, Dr. Michael T. Scerba, Dr. Nathaniel I. Shank, Tracy L. Hartman, Caitlin A. Buchholz, Dr. Robert W. Buckheit Jr., Dr. Stewart R. Durell and Dr. Daniel H. Appella
Version of Record online: 25 APR 2017 | DOI: 10.1002/cmdc.201700141
The bare-knuckle round in the fight against HIV: Mercapotobenzamide derivatives could become the next generation of drugs to treat HIV infection by targeting and inactivating nucleocapsid protein 7 (NCp7). This protein contains two zinc-coordinated knuckles that bind to HIV RNA and are essential for viral replication. Certain mercaptobenzamide derivatives promote the acetylation of NCp7, loss of zinc coordination, and eliminate the ability of NCp7 to bind HIV RNA. Herein we describe how to quickly make mercaptobenzamide analogues to screen for antiviral activity.
- Synthesis and SAR Study of Novel Anticancer Protoflavone Derivatives - Investigation of Cytotoxicity and Interaction with the ABCB1 and ABCG2 Multidrug Efflux Transporters
Balázs Dankó, Szilárd Tóth, Ana Martins, Vágvölgyi Máté, Norbert Kúsz, Joseph Molnár, Fang-Rong Chang, Yang-Chang Wu, Gergely Szakács and Attila Hunyadi
Accepted manuscript online: 23 APR 2017 09:20PM EST | DOI: 10.1002/cmdc.201700225
- Novel, selective and developable Dopamine D3 antagonists with modified "amino" region.
Accepted manuscript online: 20 APR 2017 09:26AM EST | DOI: 10.1002/cmdc.201700148